PMID: 3757924Jun 1, 1986Paper

Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans

Endocrinologia Japonica
M KabutoY Saitoh

Abstract

Plasma melatonin levels were determined every 20 and 30 min for 24 hours on the last day of repeated oral administrations (1 or 2 mg a day for 8 or 9 days) of a benzodiazepine derivative (450191-s), which is known to be metabolized to active benzodiazepines after administration. In one of the two subjects, the nocturnal enhancement of plasma melatonin which was obvious on a control day with placebo was diminished almost completely. In the other subject, observed were not only the diminishment of its nocturnal enhancement but also its increase during the daytime almost to the nocturnal levels on a control day, which may indicate a rebound increase in melatonin synthesis or a shift in its day-night rhythmicity. Such suppressing effects of benzodiazepines on the nocturnal plasma melatonin levels were also examined in the case of a single administration of 2 mg of 450191-s or flunitrazepam in the second series of experiments. Even a single flunitrazepam seemed to have lowered nocturnal plasma melatonin levels, which then recovered to the usual levels following the administration of 5 mg of a benzodiazepine antagonist, Ro 15-1788, given 6 hours after the flunitrazepam. However, single 450191-s did not show any remarkable effects. Th...Continue Reading

Citations

Dec 1, 1987·Cellular and Molecular Neurobiology·D P Cardinali, M I Vacas
Jan 1, 1994·Life Sciences·G L Brammer
Jul 1, 1991·Psychiatry Research·L J WhalleyJ Bennie
Jan 1, 1988·Neurochemistry International·P Govitrapong, M Ebadi
Jan 1, 1989·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·P GovitrapongM Ebadi
May 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·G HajakE Rüther
Aug 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·K MannO Benkert
Jun 1, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·T R NormanG D Burrows
Oct 25, 2003·Psychoneuroendocrinology·M CrassonJ J Legros
Jun 15, 2013·Sleep Disorders·Jo SpongDavid J Berlowitz
May 26, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·A L MoreraM Henry
Apr 5, 2016·International Journal of Molecular Sciences·Yung-Sen Chang, Bor-Luen Chiang
Jun 19, 2015·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Lone BaandrupBirte Y Glenthoj
Jan 16, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jaime M MontiGregory M Brown
Jan 1, 1994·Journal of Psychopharmacology·N H AllenC Thompson
Oct 31, 1998·Journal of Child Neurology·A Muñoz-HoyosD Acuña-Castroviejo
Jun 27, 2018·Pediatric Dermatology·Emily BoozalisShawn G Kwatra
May 1, 1995·Clinical Pharmacology and Therapeutics·I V ZhdanovaD L Schomer
Jun 1, 1993·Chronobiology International·I M McIntyreS M Armstrong
Nov 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·A Cavallo
Jan 29, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Rituparna MaitiSantanu Nath
Mar 13, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Mark K GreenwaldTimothy A Roehrs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.